tonabersat
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2006 (NCT00311662)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
CC(=O)c1ccc2c(c1)[C@H](NC(=O)c1ccc(F)c(Cl)c1)[C@H](O)C(C)(C)O2- Mol. weight
- 391.83 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL318191 ↗
Also known as
- 6-acetyl-4-(3-chloro-4-fluorobenzoylamino)-3,4-dihydro-2,2-dimethyl-2h-benzo(b)pyran-3-ol
- sb 220453
- sb-220453
- sb-220453
- sb-220453
- tonabersat
- tonabersat
- tonabersat
- tonabersat
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00534560 | Phase 2 | Oct 1, 2007 | Minster Research Ltd, Yeshiva University |
| NCT00332007 | Phase 2 | May 1, 2006 | Minster Research Ltd, University of Copenhagen |
| NCT00311662 | Phase 2 | Apr 1, 2006 | Minster Research Ltd, University of London |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Minster Research Ltd | For profit | 3 | 3 | 1 | 2006 |
| University of Copenhagen | Academic/Hospital | 1 | 0 | 1 | 2006 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Yeshiva University | Academic/Hospital | 1 | 0 | 1 | 2007 |
4 organizations
Page 1 / 1